Dupilumab: tested with established drugs
35 studies: they are given beside it. Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)RecruitingNCT06665971Phase 4Report a problem
- Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerRecruitingNCT06637306Early Phase 1Report a problem
- Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)RecruitingNCT05263206Phase 3Report a problem
- Dupilumab in Chinese Adult Participants With CRSwNPCompletedNCT05878093Phase 3Results postedReport a problem
- Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)TerminatedNCT05545072Phase 3Results postedReport a problem
- Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic EsophagitisCompletedNCT05247866Phase 4Results postedReport a problem
- Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)CompletedNCT04681729Phase 3Results postedReport a problem
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationCompletedNCT04456673Phase 3Results postedReport a problem
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous PemphigoidCompletedNCT04206553Phase 2/3Results postedReport a problem
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)CompletedNCT04202679Phase 3Results postedReport a problem
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)CompletedNCT04183335Phase 3Results postedReport a problem
- Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)CompletedNCT04180488Phase 3Results postedReport a problem
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationCompletedNCT03930732Phase 3Results postedReport a problem
- Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT03912259Phase 3Results postedReport a problem
- Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)CompletedNCT03682770Phase 2Results postedReport a problem
- Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)CompletedNCT03560466Phase 3Results postedReport a problem
- Evaluation of Dupilumab in Children With Uncontrolled AsthmaCompletedNCT02948959Phase 3Results postedReport a problem
- A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal PolypsCompletedNCT02912468Phase 3Results postedReport a problem
- Controlled Clinical Study of Dupilumab in Patients With Nasal PolypsCompletedNCT02898454Phase 3Results postedReport a problem
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedNCT02573233Phase 2Results postedReport a problem
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaCompletedNCT02528214Phase 3Results postedReport a problem
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)CompletedNCT02414854Phase 3Results postedReport a problem
- An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of SinusitisCompletedNCT01920893Phase 2Results postedReport a problem
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaCompletedNCT01854047Phase 2Results postedReport a problem
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedNCT01312961Phase 2Results postedReport a problem
- Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsCompletedNCT07646548Phase 1Report a problem
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaActive, not recruitingNCT06572228Phase 4Report a problem
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingNCT05535738Phase 2/3Report a problem
- Olfactory Outcomes of Dupilumab Treatment for Nasal PolyposisCompletedNCT04869436Phase 4Report a problem
- Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular EczemaActive, not recruitingNCT04600362Phase 2Report a problem
- Dupilumab for Prevention of Recurrence of CRSwNP After ESSCompletedNCT04596189Phase 4Report a problem
- Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal PolyposisActive, not recruitingNCT04430179Phase 2Report a problem
- Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.CompletedNCT03884842Phase 3Report a problem
- Efficacy and Safety Study of Dupilumab in Patients With Persistent AsthmaCompletedNCT03782532Phase 3Report a problem
- Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)CompletedNCT02647086Phase 1Report a problem